YBL-001

N/A

Report date: 2023/11/20 14:44:51

Base Information

Drug NameYBL-001
Drug Alias NameYBL-001AR-001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionProtein delta homolog 1 inhibitors
TargetsProtein delta homolog 1
Therapy Area/IndicationsSmall Cell Lung CarcinomaLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLegochem Biosciences IncY-biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesY-biologics Inc
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung CarcinomaLiver Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A